Imerys is engaged in the production and the processing of minerals. Co.'s operations can be divided into four business groups: Minerals for Ceramics, Refractories, Abrasives and Foundry (minerals mainly for floor tiles, sanitaryware, porcelain, mobile energy as well as high-temperature and abrasive industries); Performance and Filtration Minerals (plastics, rubber, coatings, sealants and adhesives, health, beauty and filtration of nutrition liquids); Pigments for Paper (filler and coating products for paper) and Materials and Monolithics (construction materials in clay and slate and monolithic products and solutions for high-temperature industries).
  • TickerNK
  • ISINFR0000120859
  • ExchangeEuronext Paris
  • SectorMining
  • CountryFrance

Analysts

Thanks to a better fundamental star rating, IMERYS sees an upgrade to Neutral

The independent financial analyst theScreener just awarded an improved star rating to IMERYS (FR), active in the Building Materials & Fixtures industry. As regards its fundamental valuation, the title receives an improved star rating and now shows 3 out of 4 possible stars. With regard to its market behaviour, it remains unchanged and can be qualified as risky. theScreener considers that these elements allow slightly upgrading its rating to Neutral. As of the analysis date November 5, 2019, the closing price was EUR 37.88 and its expected value was estimated at EUR 35.62.

Alain William ...
  • Christophe Chaput
  • Emira Sagaama
  • Jean-François Granjon
  • Jeremy Garnier
  • Jerôme Bodin
  • Martial Descoutures
  • Matthias Desmarais
  • Michael Foundoukidis
  • Oussema Denguir
  • Stephane Houri
  • Sven Edelfelt
  • Virginie Rousseau

ODDO BHF Small & MIDCAP MORNING NEWS - 10/31/2019 Date Performance since listing Date Performance since listing

...

Ahmed Ben Salem ...
  • Alfred Glaser
  • Antoine Boivin-Champeaux
  • Baptiste Lebacq
  • Delphine Brault
  • Emmanuel Matot
  • François Maury
  • Georges Dieng
  • Jean Sassus
  • Louis Boujard, CFA
  • Martial Descoutures
  • Oussema Denguir
  • Philippe Ourpatian
  • Steven Gould
  • Sven Edelfelt
  • Virginie Rousseau
  • Yan Derocles
  • Yassine Batini

ODDO BHF SECURITIES MORNING NEWS – DETAILED COMMENTS 10/31/2019

...

Ahmed Ben Salem ...
  • Alfred Glaser
  • Antoine Boivin-Champeaux
  • Baptiste Lebacq
  • Delphine Brault
  • Emmanuel Matot
  • François Maury
  • Georges Dieng
  • Jean Sassus
  • Louis Boujard, CFA
  • Martial Descoutures
  • Oussema Denguir
  • Philippe Ourpatian
  • Steven Gould
  • Sven Edelfelt
  • Virginie Rousseau
  • Yan Derocles
  • Yassine Batini

ODDO BHF SECURITIES MORNING NEWS – COMMENTAIRES DETAILLES 31/10/2019

...

Alain William ...
  • Christophe Chaput
  • Emira Sagaama
  • Jean-François Granjon
  • Jeremy Garnier
  • Jerôme Bodin
  • Martial Descoutures
  • Matthias Desmarais
  • Michael Foundoukidis
  • Oussema Denguir
  • Stephane Houri
  • Sven Edelfelt
  • Virginie Rousseau

ODDO BHF Small & MIDCAP MORNING NEWS - 31/10/2019

...

Marnik Hinnekens

TP ICAP - Europe - Morning CreditUpdate 30/10/2019 - Fiat Chrysler Automobiles (Achat) – Peugeot (Achat) - EN

Fiat Chrysler Automobiles (O/P) - Peugeot (O/P): Confirm Merger Talks Unicaja Banco: Tier 2 10NC5 Bond Issue Santander (O/P) - 9M-19:  Revenues of €37.0bn (+2.8%) Deutsche Bank (U/P) - 9M-19: Net Loss of €4.1bn (vs Net Profit of €455m A Year Earlier) Pirelli (O/P) - 9M-19: EBITDA of €979m (+7.8%) Fresenius (M/P) - 9M-19: EBITDA of €4.5bn (+2.7%) Atos (O/P): Completes The Sale of Worldline and €500m Convertible Issue Stora Enso (O/P) - 9M-19: EBIT of €841m (-20.2%)

Marnik Hinnekens

TP ICAP - Europe - Morning CreditUpdate 30/10/2019 - Fiat Chrysler Automobiles (Achat) – Peugeot (Achat) - FR

Fiat Chrysler Automobiles (Achat) – Peugeot (Achat) : Nouvelles discussions sur une fusion des deux groupes Unicaja Banco : Emission d'une obligation Tier 2 10NC5 Santander (Achat) - 9M-19 : PNB de €37,0 mds (+2,8%) Deutsche Bank (Vente) - 9M-19 : Perte nette de €4,1mds (RN de €455m un an avant) Pirelli (Achat) - 9M-19 : EBITDA de €979m (+7,8%) Fresenius (Conserver) - 9M-19 : EBITDA de €4,5 mds (+2,7%) Atos  (Achat) : Finalise la cession de Worldline et émission convertible de €500m Stora Enso (Achat) - 9M-19 : EBIT de €841m (-20...

Marnik Hinnekens

TP ICAP - Europe - Morning CreditUpdate 29/10/2019 - AT&T - EN

AT&T: Plans $5bn To $10bn Of Assets Disposal In 2020 Commerzbank (U/P) -Q3-19: Net Profit of €294m (+34.9%) Mediobanca (O/P) - Q1-19/20: Net Profit of €271m (+10.3%) Bharti Airtel (U/P): Postpones The Publication of Its Half Year Results Orange (Outperform: Hybrids) - 9M-19: EBITDA (After Leases) of €9.6bn (+0.6% LfL) Unibail-Rodamco-Westfield (M/P) - 9M-19: Revenues of €2.2bn (+17.7%) Imerys (O/P) - 9M-19: Current Operating Income of €358m (-15.7%) S&P Affirms RCI Banque's BBB Rating (O/P), the Outlook Remains Negative

Marnik Hinnekens

TP ICAP - Europe - Morning CreditUpdate 29/10/2019 - AT&T - FR

AT&T : Prévoit de céder $5 mds à $10mds d’actifs en 2020 Commerzbank (Vente) -T3-19:  RN de €294m (+34,9%) Mediobanca (Achat) - T1-19/20 : RN de €271m (+10,3%) Bharti Airtel (Vente) : Reporte la publication de ses résultats semestriels Orange (Achat hybrides) - 9M-19 : EBITDA (après leases) de €9,6 mds (+0,6% en comparable) Unibail-Rodamco-Westfield (Conserver) – 9M-19 : Revenus de €2,2 mds (+17,7%) Imerys (Achat) - 9M-19 : Résultat opérationnel courant de €358m (-15,7%) S&P confirme la note BBB de RCI Banque (Achat), la perspe...

Marnik Hinnekens

TP ICAP - Europe - Morning CreditUpdate 22/10/2019 - Teva - EN

TP ICAP - Europe - Morning CreditUpdate 22/10/2019 - Teva - EN

Sven Edelfelt ...
  • Virginie Rousseau

Imerys : J&J and the FDA; the war of words

>J&J finds no trace of asbestos in its baby powder bottle - Unlike the FDA (Food and Drug Administration), and after a second opinion, Johnson & Johnson has found no trace of asbestos in the baby powder bottle of batch #22318RB. Johnson & Johnson voluntarily recalled 33,000 bottles (batch#22318RB) to check the integrity of the bottle tested. The recall followed an FDA test that revealed low levels of chrysotile asbestos contamination in samples taken from a bottle pu...

Sven Edelfelt ...
  • Virginie Rousseau

Imerys : J&J et la FDA ; la guerre des mots

>J&J ne trouve pas de trace d’amiante dans son flacon - A l’inverse de la FDA (Food and Drug Administration), et après une contre-expertise, Johnson & Johnson n’a pas trouvé d'amiante dans le flacon du lot #22318RB. Rappelons que la société a lancé le rappel volontaire de 33 000 flacons (lot #22318RB) pour vérifier l'intégrité de la bouteille testée. Le rappel faisait suite à un test de la FDA qui avait révélé de faibles niveaux de contamination par l'amiante chrysoti...

Sven Edelfelt ...
  • Virginie Rousseau

Imerys : Q3 characterised by a worsening trend

>Operating profit consistent with the warning issued on 22 October - Q3 2019 operating profit below our expectations, in line with the Q3 warning already discussed in our flash of 22 October (details on page 2). It came in at € 113m (-19.8% and -14.6% l-f-l) vs ODDO BHF at € 122m (no consensus) and the margin was 10.5%, down 180bp after a decline of 120bp in Q2. The group continued to be hit by the problems of deconsolidating the US talc business (€ 4m) and the declin...

Eric Lemarie

IMERYS: Tough Q3. Cautious outlook. | SELL | EUR31 vs. EUR51 (-11%)

IMERYS - SELL | EUR31 vs. EUR51 (-11%) Tough Q3. Cautious outlook. Q3 revenue under pressure. Q4 unlikely to be better. Further decline in current operating margin in Q3 Reorganisation plan ongoing, CMD financials targets confirmed New valuation: from EUR51 to EUR31

Sven Edelfelt ...
  • Virginie Rousseau

Imerys : T3 2019 sous le signe de la dégradation

>Résultat opérationnel conforme au warning du 22 octobre - Résultat opérationnel T3 2019 inférieur à nos attentes, cohérent avec le warning du T3 déjà commenté dans notre flash du 22 octobre dernier (détails en page 2). Il ressort à 113°M€ (-19.8% et -14.6% à pcc) vs ODDO BHF à 122°M€ (pas de consensus) et la marge à 10.5% en recul de 180 pb après un recul de 120 pb au T2. Le groupe a continué de souffrir des problèmes de la déconsolidation du Talc US (4 M€) et de la ...

1 director bought

A director at Imerys Sa bought 600 shares at 41.000EUR and the significance rating of the trade was 53/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activity is restricted under listing rules. The names of board membe...

Alain William ...
  • Christophe Chaput
  • Emira Sagaama
  • Jean-François Granjon
  • Jeremy Garnier
  • Jerôme Bodin
  • Martial Descoutures
  • Matthias Desmarais
  • Michael Foundoukidis
  • Oussema Denguir
  • Stephane Houri
  • Sven Edelfelt
  • Virginie Rousseau

ODDO BHF Small & MIDCAP MORNING NEWS - 10/31/2019 Date Performance since listing Date Performance since listing

...

Ahmed Ben Salem ...
  • Alfred Glaser
  • Antoine Boivin-Champeaux
  • Baptiste Lebacq
  • Delphine Brault
  • Emmanuel Matot
  • François Maury
  • Georges Dieng
  • Jean Sassus
  • Louis Boujard, CFA
  • Martial Descoutures
  • Oussema Denguir
  • Philippe Ourpatian
  • Steven Gould
  • Sven Edelfelt
  • Virginie Rousseau
  • Yan Derocles
  • Yassine Batini

ODDO BHF SECURITIES MORNING NEWS – DETAILED COMMENTS 10/31/2019

...

Ahmed Ben Salem ...
  • Alfred Glaser
  • Antoine Boivin-Champeaux
  • Baptiste Lebacq
  • Delphine Brault
  • Emmanuel Matot
  • François Maury
  • Georges Dieng
  • Jean Sassus
  • Louis Boujard, CFA
  • Martial Descoutures
  • Oussema Denguir
  • Philippe Ourpatian
  • Steven Gould
  • Sven Edelfelt
  • Virginie Rousseau
  • Yan Derocles
  • Yassine Batini

ODDO BHF SECURITIES MORNING NEWS – COMMENTAIRES DETAILLES 31/10/2019

...

Alain William ...
  • Christophe Chaput
  • Emira Sagaama
  • Jean-François Granjon
  • Jeremy Garnier
  • Jerôme Bodin
  • Martial Descoutures
  • Matthias Desmarais
  • Michael Foundoukidis
  • Oussema Denguir
  • Stephane Houri
  • Sven Edelfelt
  • Virginie Rousseau

ODDO BHF Small & MIDCAP MORNING NEWS - 31/10/2019

...

Christophe-Raphaël Ganet ...
  • Geoffroy Michalet
  • Nicolas Thorez
  • Sven Edelfelt
  • Virginie Rousseau

ODDO BHF Small & MIDCAP MORNING NEWS - 10/29/2019

A recovery story against a less favourable macroeconomic backdrop and amid further tough competition. A self-help plan rolled out by the new management team under good auspices with EBITDA expected to pick up by a net € 175m in 2021, implying a 2018-2021 CAGR of +15.5%. With a foothold in a long-cycle business, the group should show greater resilience. Buy recommendation reiterated, target price adjusted to € 41 from € 40. Cf. company report published this morning. - ...

Thanks to a better fundamental star rating, IMERYS sees an upgrade to Neutral

The independent financial analyst theScreener just awarded an improved star rating to IMERYS (FR), active in the Building Materials & Fixtures industry. As regards its fundamental valuation, the title receives an improved star rating and now shows 3 out of 4 possible stars. With regard to its market behaviour, it remains unchanged and can be qualified as risky. theScreener considers that these elements allow slightly upgrading its rating to Neutral. As of the analysis date November 5, 2019, the closing price was EUR 37.88 and its expected value was estimated at EUR 35.62.

Ford Equity International Rating and Forecast Report

Ford Equity International Research Reports cover 60 countries with over 30,000 stocks traded on international exchanges. A proprietary quantitative system compares each company to its peers on proven measures of business value, growth characteristics, and investor behavior. Ford's three recommendation ratings buy, hold and sell, represent each stock’s return potential relative to its own country market.. The rating reports which are generated each week, include the fundamental details behind each recommendation and reflect the fundamental and price data as of the last trading day of the week...

MarketLine Department

Compagnie de Saint-Gobain - Strategy, SWOT and Corporate Finance Report

Summary Compagnie de Saint-Gobain - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. KeyHighlights Compagnie de Saint-Gobain (Saint-Gobain) is a construction and building products manufacturing company. Its product portfolio includes various types of glasses, ceramic tiles and related products, plastics, cast iron pipes and related products, home improvement materials, gypsum, in...

MarketLine Department

Wienerberger AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments

Summary Marketline's Wienerberger AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Wienerberger AG since January2007. Marketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Key Hig...

Expert Corporate Governance Service (ECGS)

Imerys - AGM and EGM 10 May 2019

Since 4 May 2018, Conrad Keijzer, after having been Deputy Chief Executive Officer since 8 March 2018, has been Chief Executive Officer of the company, replacing Gilles Michel, who has retained the position of Chairman of the Board of Directors. The remuneration policy of the new Chief Executive Officer allows excessively generous amounts and the proposed amendments are inflationary in nature. The same applies to severance pay, which cannot also be supported (resolutions 4 and 6). Gilles Michel's remuneration as Chairman of the Board of Directors seems acceptable, however, as well as the exc...

Charles Pinel

Imerys - Assemblée Générale des actionnaires du 10 mai 2019

Depuis le 4 mai 2018, Conrad Keijzer, après en avoir été Directeur Général Délégué depuis le 8 mars 2018, est Directeur Général de la société en remplacement de Gilles Michel qui a conservé la Présidence du Conseil d'administration. La politique de rémunération du nouveau Directeur général permet des montants trop généreux et les modifications proposées ont un caractère inflationniste. Il en est de même des indemnités de départ qui ne pourront également pas être soutenues (résolutions 4 et 6). La rémunération de Gilles Michel en tant que Président du Conseil d'administration semble en revanc...

Imerys – Proxinvest Corporate Governance Rating ® : C

Proxinvest Corporate Governance Rating ® helps investors integrate governance into their investment decision and identify governance risks and opportunities within their portfolio. Proxinvest Corporate Governance Rating ® Service rates European issuers through the analysis of four main themes : Ownership & Shareholder rights, Board & Committees, Audit & Process, Remuneration. Each theme is rated taking into account several comprehensive sub-categories. Our unique two-step process to achieve each rating includes a first step quantitative valuation and a second step qualitative filter...

Charles Pinel

Proxy Report - 04/05/2018

Gilles Michel, CEO, will resign on the 4th of May, 2018. Conrad Keijzer, appointed as deputy Chief Executive Officer on March 8, 2018, will be designated as Chief Executive Officer of the Group. We welcome the separation of functions (resolutions 7 and 10). The Board will decide at its meeting on May 4, 2018 to coopt a new independent female member who is currently being selected. 2017 remuneration for Gilles Michel : The Company has made a concerted effort to improve transparency this year by disclosing performance criteria weightings and achievement rates for the bonus. However, given the l...

Charles Pinel

Proxy Report - 04/05/2018

Président-Directeur Général d'Imerys depuis 2011, Gilles Michel va prendre sa retraite à l'issue de la présente assemblée générale. Il conservera la présidence du conseil et Conrad Keijzer, désigné le 8 mars 2018 en qualité de Directeur général délégué, deviendra Directeur général. En raison de la séparation des fonctions de président du conseil et de Directeur général, nous recommandons l'approbation aux résolutions 7 et 10 (renouvellement du mandat de Gilles Michel et nomination de Conrad Keijzer). Par ailleurs, le Conseil a exprimé sa volonté de coopter, lors de sa réunion du 4 mai prochai...

Jérôme VINERIER

Short term view - IMERYS : The background trend is clearly bearish.

The background trend is clearly bearish. Prices are falling again, but the movement has become hesitant. The next support is at €52.05. The background trend would be questioned should prices rise above €64.70.

Jérôme VINERIER

Analyse court terme - IMERYS : La tendance de fond est clairement orientée à la baisse.

La tendance de fond est clairement orientée à la baisse. Les prix baissent à nouveau, mais le mouvement est devenu hésitant. Le prochain support est à 52,05 €. La tendance de fond serait remise en cause en cas de franchissement de 64,70 €.

Jérôme VINERIER

Analyse court terme - IMERYS : La tendance de fond est clairement orientée à la baisse.

La tendance de fond est clairement orientée à la baisse. Le mouvement se poursuit. Le prochain objectif est à 52,05 €, puis 46,47 €. Le franchissement de 64,70 € remettrait en cause la suite de la baisse.

Jérôme VINERIER

Short term view - IMERYS : The background trend is clearly bearish.

The background trend is clearly bearish. The movement goes on. The next target is at €52.05, then €46.47. Passing €64.70 would question the continuation of the fall.

Jérôme VINERIER

Analyse moyen terme - IMERYS : La tendance est baissière.

La tendance est baissière. Le mouvement se poursuit. Le prochain objectif est à 52,20 €, puis 46,30 €. Le franchissement de 70,03 € remettrait en cause la suite de la baisse.

ResearchPool Subscriptions

Get the most out of your insights

Get in touch